Tamtam Try Tamtam free
Ascension logo

Ascension account plan

Healthcare services and innovation

At a glance

Ascension is a US Catholic nonprofit health system with 91 consolidated hospitals, 98,500 associates and $24,473 million FY2026 operating revenue.

Ascension is one of the largest Catholic, nonprofit health systems in the United States, sponsored by five religious congregations and organised in regional Ministry Markets such as Ascension Seton (Texas), Ascension Saint Thomas (Tennessee) and Ascension St. Vincent (Indiana). At September 30, 2026 it had about 98,500 associates and 27,700 aligned providers across 35 states and the District of Columbia, 91 wholly owned or consolidated hospitals, interests in 32 more, 306 ambulatory surgery centers and 20 senior living facilities. In the fiscal year ended June 30, 2026 total operating revenue was $24,473 million, the loss from operations $120 million and net income $1,505 million, driven by investment gains. The June 2026 acquisition of AmSurg made it a large ambulatory surgery platform. Eduardo Conrado has been President and CEO since January 1, 2026.

Business units

Strategic priorities

Shift care to ambulatory settings
Ascension is expanding ambulatory, virtual and community-based care and moving procedures out of hospitals; ambulatory and ancillaries grew at a 20 percent compound annual rate over four years.
Grow through AmSurg
AmSurg lets Ascension enter 25 new markets through surgery centers and partnerships with independent physicians and health systems, without building acute hospitals.
Margin targets
Ascension targeted an operating income margin of 0.5% for FY2026, about 2% by fiscal 2027 and about 3% by fiscal 2028, with M&A potentially lifting it to roughly 4%.
Ancillaries and pharmacy
Growth in imaging, outpatient therapy and Ascension Rx specialty pharmacy and national mail order is a stated priority.
Access for Medicaid and uninsured patients
With more than one million patients a year on Medicaid or uninsured, Ascension is extending hours, virtual care and FQHC data sharing to reduce emergency department overuse.
AI in care and access
The CEO expects AI to play a significant role in clinical settings, access, consumer interaction and scheduling.

Latest results

In the first quarter of fiscal 2027 (three months to September 30, 2026), the first full quarter with AmSurg, total operating revenue rose to $6,447 million from $6,136 million and net patient service revenue 9.3% to $5,890 million. Recurring operating EBIDA was $229 million, a 3.6% margin against 3.4%, while the recurring operating loss stayed at $86 million. Operating expenses rose 4.4%, led by salaries and supplies. Lower investment gains ($169 million against $569 million) turned net income to a $34 million loss. Days cash on hand fell to 219. For full FY2026, same-facility operating revenue rose 9.8% to $24.1 billion. No numeric guidance is published in the financial documents.

Investments and deals

AmSurg acquisition
Ascension acquired AmSurg in June 2026 for about $3.8 billion (announced as a $3.9 billion agreement), bringing roughly 300 ambulatory surgery centers.
Hospital acquisitions
Ascension bought Cedar Park Regional Medical Center in June 2025, is acquiring Williamson Health in Tennessee, and signed in October 2026 to acquire 3 healthcare facilities from Cedar Park in Texas.
Facility projects
Projects include a new patient tower at Ascension Seton Williamson, a 40-bed inpatient rehabilitation facility in Florida, an east Wichita emergency department and a $120 million campus renovation at Ascension Saint Thomas Hospital West; construction commitments were about $769 million at June 30, 2026.
Divestitures
Since 2024 Ascension sold or contributed hospitals in Michigan, Chicago and Alabama, and sold the Mercy Care health plan to CVS Pharmacy in October 2026.
Bond financing
Ascension raised about $2.1 billion of taxable bonds in November 2025 and about $2.5 billion of tax-exempt bonds in December 2025 for capital projects and refundings.

Challenges and risks

Cost inflation
Average hourly wages rose 4.3% in FY2026, and supplies rose 12.1% in Q1 FY2027 on high-cost devices and pharmaceuticals, alongside rising provider taxes.
Rising uninsured population
Medicaid reductions and the loss of ACA tax credits are expected to increase the number of uninsured patients Ascension serves.
AmSurg integration
The CFO says making the acquisition successful "is a whole other journey", and the purchase price allocation stays provisional until June 4, 2027.
Leverage and investment dependence
Total debt to capitalization rose to 31.1% from 22.0%, Fitch downgraded Ascension to AA, and the bottom line depends heavily on investment returns.

What leadership says

“Success is no longer defined by the number of hospitals in a portfolio, but by whether people can access care when and where they need it.”

Eduardo Conrado, President and CEO · Scottsdale Institute CEO Viewpoint, April 2026

“The ambulatory space has a 10%-plus CAGR going forward, and then our acute side, for the markets that we're in, about 3%.”

Eduardo Conrado, President and CEO · J.P. Morgan Healthcare Conference, reported January 30, 2026

“Healthcare is increasingly moving beyond the traditional hospital setting, and this acquisition positions us to lead that transformation.”

Eduardo Conrado, President and CEO · AmSurg deal-closing announcement, reported June 10, 2026

“One thing we will never walk away from is our mission …. but we do want to take the care out of hospitals.”

Saurabh Tripathi, Executive Vice President and CFO · HFMA conference panel, reported June 10, 2026

Where a supplier can help

Ambulatory surgery operations
Integrating AmSurg and entering 25 new markets creates needs for ASC equipment, scheduling, staffing and integration services.
Supply and device cost control
Supply costs rising on devices and pharmaceuticals, with mitigation run through The Resource Group, favour suppliers that cut implant, catheter or drug cost.
AI for access and scheduling
The CEO's view that AI will matter in access, consumer interaction and scheduling, plus virtual care for uninsured patients, opens room for digital front door and scheduling tools.
Specialty pharmacy and mail order
The Ascension Rx priority on specialty pharmacy and national mail order fits pharmacy logistics and fulfilment partners.
Margin improvement
Targets of about 2% operating margin by fiscal 2027 and about 3% by fiscal 2028 reward vendors that lower cost per case or improve revenue cycle.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Ascension?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Ascension

What does Ascension do?

Ascension is a Catholic, nonprofit US health system that runs hospitals, ambulatory surgery centers, physician practices, pharmacies and senior living facilities across 35 states and the District of Columbia.

What is Ascension's revenue?

Total operating revenue was $24,473 million in the fiscal year ended June 30, 2026, and $6,447 million in the quarter ended September 30, 2026.

How many employees does Ascension have?

Ascension had about 98,500 associates and 27,700 aligned providers at September 30, 2026.

Who leads Ascension?

Eduardo Conrado has been President and CEO since January 1, 2026, succeeding Joseph Impicciche; Saurabh Tripathi is Executive Vice President and CFO.

Why did Ascension buy AmSurg?

AmSurg's surgery centers let Ascension move lower-acuity procedures out of hospitals into lower-cost settings and enter 25 new markets with physician partners, without building new hospitals.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)